South Bend, Indiana news: Stopping migraines before they start
Migraines affect millions of people in the United States, but a recent study from the American Academy of Neurology found people who suffer migraines might be able to predict when one is coming hours before symptoms even start.
Vince Martin, MD, professor in the Department of Internal Medicine in UC's College of Medicine and director of the Headache and Facial Pain Center at the University of Cincinnati Gardner Neuroscience Institute, was not involved in the research but commented on it to South Bend, Indiana television station WNDU. He said migraines are some of the most common conditions treated in his practice.
Migraines occur in about 16 to 18% of women and 5% of men, Martin said, or 12% of the total population. They can last from four to 72 hours, causing moderate to severe pain.
“Usually, the pain is on one side, but occasionally it can be two-sided,” Martin said. “And they get a variety of different symptoms such as nausea, and vomiting, and sometimes sensitivity to light and noise as well.”
The recent study found circadian rhythms play a huge role in migraines. Study participants who experienced poor sleep quality and low energy had a higher chance of a migraine the next morning. For people who had higher energy and higher stress levels, a migraine also typically followed the next day — but in the afternoon or evening.
Doctors say recognizing specific triggers means a migraine could be predicted and prevented with medication before it even starts.
“We use some of the (medications) that stay in the body a little bit longer shortly before a trigger and during the trigger, and then sometimes that can kind of ward it off," Martin said.
Featured photo at top of a man with migraine symptoms.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.